AMY1基因拷贝数与葡萄糖吸收及内脏脂肪体积相关,但与胰岛素抵抗无关
研究从尿液、血清和口腔样本提取DNA,用微滴数字PCR测定AMY1拷贝数,分析其与代谢指标及口服淀粉挑战后血糖反应的关系。结果显示AMY1拷贝数与内脏脂肪体积呈负相关,与口服葡萄糖胰岛素敏感性评分、HDL胆固醇和脂联素呈正相关,与胰岛素抵抗无关;高拷贝数组口服淀粉后血糖升幅更大。
要点
- AMY1拷贝数与内脏脂肪体积呈负相关(CC -0.33;P=0.004)。
- AMY1拷贝数与口服葡萄糖胰岛素敏感性评分正相关(CC 0.26;P=0.02)。
- 高AMY1拷贝数组口服淀粉后血糖升幅大于低拷贝数组(1.7 vs 0.9 mmol/l;P=0.016)。
核心结论
- 高AMY1拷贝数与有利的代谢特征相关(较低内脏脂肪体积、较高血清脂联素、口服葡萄糖及口服淀粉后葡萄糖吸收增强),但与全身或肝脏胰岛素抵抗无关。
研究设计与样本
- 从ProFiMet队列的尿液(n=74)和血清(n=6)样本及OSC队列的口腔样本(n=17)提取DNA,用微滴数字PCR评估AMY1拷贝数。
- 在ProFiMet队列中用Pearson相关系数分析AMY1拷贝数与综合代谢标志物的关联。
- 在健康血糖正常的OSC队列中用独立样本t检验分析口服淀粉挑战后的血糖反应,亚组为高AMY1拷贝数9-12(n=10)和低AMY1拷贝数4-6(n=7)。
主要发现
- AMY1拷贝数与总内脏脂肪体积呈显著负相关(CC -0.33;P=0.004)。
- AMY1拷贝数与口服葡萄糖胰岛素敏感性评分呈正相关(CC 0.26;P=0.02)。
- AMY1拷贝数与血清HDL胆固醇呈正相关(CC 0.325;P=0.003),与血清脂联素呈正相关(CC 0.249;P=0.026)。
- 以脂联素为因变量的线性回归多变量分析显示脂联素与AMY1拷贝数独立相关(Beta=0.29;P=0.03)。
- AMY1拷贝数与钳夹衍生M值、稳态模型评估的胰岛素抵抗、肝脏内源性葡萄糖生成、粪便菌群特征或宏量营养素饮食偏好无显著关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The human amylase gene (AMY1) has a broad copy number (CN) variation that may associate with body mass index. METHODS: Deoxyribonucleic acid was extracted from urine (n = 74) and serum (n = 6) samples (Protein, Fiber and Metabolic Syndrome [ProFiMet] cohort), and buccal (n = 17) samples (Oral Starch Challenge [OSC] cohort), and assessed for AMY1 CN by droplet digital polymerase chain reaction. The association of AMY1 CN with comprehensive markers of metabolic status (ProFiMet cohort) were analyzed with Pearson's correlation coefficient (CC). For the healthy, euglycemic OSC cohort, glycemic response to OSC was analyzed with independent sample t-tests (subgroups: high AMY1 CN 9-12, n = 10; low AMY1 CN 4-6, n = 7). RESULTS: There were significant inverse correlations of AMY1 CN with total visceral fat volume (CC -0.33; P = 0.004) and positive correlations of AMY1 CN with oral glucose insulin sensitivity score (derived from an oral glucose tolerance test, CC 0.26; P = 0.02), serum HDL-cholesterol (CC 0.325; P = 0.003), and serum adiponectin (CC 0.249; P = 0.026). Linear regression multivariate analysis (adiponectin as dependent variable), showed independent association of adiponectin with AMY1 CN (Beta = 0.29; P = 0.03). There were no significant associations between AMY1 CN and clamp-derived M-value, homeostasis model assessment of insulin resistance (IR), hepatic endogenous glucose production, fecal floral signature, or macronutrient dietary preference. Delta (mean) change in blood glucose concentration (fasting to 30-minutes post-OSC) was significantly greater in the high versus low AMY1 CN subgroups (mean 1.7 mmol/l [SEM 0.6] vs 0.9 mmol/l [SEM 0.9], respectively; P = 0.016). CONCLUSIONS: High AMY1 CN associates with a favorable metabolic profile (lower visceral fat volume, higher serum adiponectin, enhanced glucose absorption following oral glucose, and OSC), but not with whole-body or hepatic IR.
引用
- Barber TM, Bhatti AA, Elder PJD, et al. AMY1 Gene Copy Number Correlates With Glucose Absorption and Visceral Fat Volume, but Not with Insulin Resistance. J Clin Endocrinol Metab. 2020. PMID: 32697825. doi:10.1210/clinem/dgaa473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。